ArticleFrontiers in clinical diabetes and healthcare2025

Exploring factors predicting the effectiveness of oral semaglutide in Japanese individuals with type 2 diabetes switching from dipeptidyl peptidase 4 inhibitors: a pilot study.

Takao Hirotsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.